Skin reactions related to treatment with anticytokines, membrane receptor inhibitors and monoclonal antibodies

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.2, Iss.5, 2003-09, pp. : 467-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

Current Medicinal Chemistry, Vol. 16, Iss. 36, 2009-12 ,pp. : 4858-4868

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4498-4507

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers

By KHAN MISBAH H. ALAM MURAD YOO SIMON

Dermatologic Surgery, Vol. 37, Iss. 9, 2011-09 ,pp. : 1199-1209

Elsevier

Access to resources Recommend Favorite

Monoclonal antibodies get to grips with skin disorders

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Anticoagulant-related skin reactions

By Jörg I Fenyvesi T Harenberg J

Expert Opinion on Drug Safety, Vol. 1, Iss. 3, 2002-09 ,pp. : 287-294

Informa Healthcare

Access to resources Recommend Favorite